Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iNeo-Vac-R01 in Biliary Malignant Tumors After Radical Resection
NCT07368803Phase 2Recruiting
- Start
- Sep 2025
- Primary completion
- Sep 2027
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of iNeo-Vac-R01 in cholangiocarcinoma (CCA). Started Sep 2025; status: recruiting.
02
Drugs
iNeo-Vac-R01
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT07368803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368803.